<p>Anti-NP IgG titers were determined by ELISA on day 60. BALB/c mice (n = 5) were vaccinated with two doses of rNP (10 µg/dose) alone or co-administered with c-di-AMP (10 µg/dose) by intranasal route, whereas control animals received PBS, at an interval of 3 weeks. (A) Anti-NP IgG titer. (B) Anti-NP IgG subclass titers. The results are expressed as mean end point titers. The S.E.M. is indicated by vertical lines. Differences were statistically significant at p<0.01 (**) or p<0.05 (*) with respect to values obtained in mice receiving the antigen alone.</p
<p>(A) Specific anti-PAc salivary IgA levels (ng/ml); (B) Specific anti-PAc serum IgG levels (µg/ml)...
<p>B6 mice were injected i.m. in both hind-legs with PBS (closed triangles) or a total of 10 µg of N...
<p>Levels of (A) anti-N-PmpC IgA and (B) anti-N-PmpC IgG and (C) ratio of the levels of N-PmpC-speci...
<p>NP-specific IgA titers measured by ELISA in nasal (NL) and BAL lavages of BALB/c mice immunized w...
<p>Mice were inoculated 2 times i.n. or i.m. with IDLV-NP, 4 weeks apart. Mice that received either ...
<p>CDH17<sup>-/-</sup> mice and their WT littermates received a primary immunization with NP-CGG in ...
<p>B6 mice were immunized i.m. in both hind-legs with a total of 10 µg of NP protein delivered with ...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>CDH17<sup>-/-</sup> mice and their WT littermates were immunized with NP-CGG in alum. (A, C) The ...
Mice were immunized by subcutaneous injection (s.c.) or by intragastric administration (i.g.) with P...
<p>Serum samples were collected two weeks after the completion of the immunizations and were assayed...
IgG (A) and IgA (B) antibody levels in serum were detected 7 days after the last immunization from t...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>After NP-CGG immunization no changes in IgE antibody responses were observed at any time point (d...
<p>Mice were immunized intranasally with two doses of the indicated formulations and anti-rPspA1(A),...
<p>(A) Specific anti-PAc salivary IgA levels (ng/ml); (B) Specific anti-PAc serum IgG levels (µg/ml)...
<p>B6 mice were injected i.m. in both hind-legs with PBS (closed triangles) or a total of 10 µg of N...
<p>Levels of (A) anti-N-PmpC IgA and (B) anti-N-PmpC IgG and (C) ratio of the levels of N-PmpC-speci...
<p>NP-specific IgA titers measured by ELISA in nasal (NL) and BAL lavages of BALB/c mice immunized w...
<p>Mice were inoculated 2 times i.n. or i.m. with IDLV-NP, 4 weeks apart. Mice that received either ...
<p>CDH17<sup>-/-</sup> mice and their WT littermates received a primary immunization with NP-CGG in ...
<p>B6 mice were immunized i.m. in both hind-legs with a total of 10 µg of NP protein delivered with ...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>CDH17<sup>-/-</sup> mice and their WT littermates were immunized with NP-CGG in alum. (A, C) The ...
Mice were immunized by subcutaneous injection (s.c.) or by intragastric administration (i.g.) with P...
<p>Serum samples were collected two weeks after the completion of the immunizations and were assayed...
IgG (A) and IgA (B) antibody levels in serum were detected 7 days after the last immunization from t...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>After NP-CGG immunization no changes in IgE antibody responses were observed at any time point (d...
<p>Mice were immunized intranasally with two doses of the indicated formulations and anti-rPspA1(A),...
<p>(A) Specific anti-PAc salivary IgA levels (ng/ml); (B) Specific anti-PAc serum IgG levels (µg/ml)...
<p>B6 mice were injected i.m. in both hind-legs with PBS (closed triangles) or a total of 10 µg of N...
<p>Levels of (A) anti-N-PmpC IgA and (B) anti-N-PmpC IgG and (C) ratio of the levels of N-PmpC-speci...